VEGFA and neoplasm: Preclinical studies in other tumors suggest that the concomitant inhibition of VEGF signalling and SFKs potentiates antitumoral effects by stabilizing the endothelial barrier function, thus preventing tumor cell extravasation, and overcoming drug resistance [159,160,161,162].